Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers





As previously disclosed, on November 14, 2021, CyrusOne Inc., a Maryland
corporation ("CyrusOne" or the "Company"), entered into an Agreement and Plan of
Merger (the "Merger Agreement") with Cavalry Parent L.P., a Delaware limited
partnership ("Parent"), and Cavalry Merger Sub LLC, a Delaware limited liability
company and a wholly owned subsidiary of Parent ("Merger Sub"), pursuant to
which, subject to the terms and conditions of the Merger Agreement, Merger Sub
will be merged with and into the Company (the "Merger"), with the Company
surviving the Merger as a wholly owned subsidiary of Parent. On December 30,
2021, the Company filed with the Securities and Exchange Commission ("SEC") a
definitive proxy statement in connection with the Merger (as previously
supplemented by the definitive additional proxy materials filed with the SEC on
January 21, 2022, the "Proxy Statement").



Following the filing of the Proxy Statement, on January 25, 2022, CyrusOne
Management Services LLC ("CyrusOne LLC"), a subsidiary of the Company, and David
H. Ferdman, the Company's President and Chief Executive Officer on an interim
basis, entered into an amendment (the "Amendment") to that certain employment
agreement, entered into by CyrusOne LLC and Mr. Ferdman on August 15, 2021 (the
"Employment Agreement"), which was set to expire on January 29, 2022 (the
"Amendment Effective Date"). The Amendment extends the term of the Employment
Agreement through the earlier of (a) the date that is 90 days after the closing
of the Merger and (b) January 29, 2023 (the "Extended Term End Date"), generally
on the same terms and conditions as the Employment Agreement except as described
below.



Under the Amendment, Mr. Ferdman's target and maximum bonus amounts set forth in
the Employment Agreement (the "Bonus") will each be multiplied by two (from
$1,000,000 to $2,000,000, and from $2,000,000 to $4,000,000, respectively) to
reflect the fact that the bonus Mr. Ferdman will be eligible to receive will be
for a period of up to one year (instead of six months under the Employment
Agreement), provided that if the Extended Term End Date occurs prior to January
29, 2023, then the Bonus will be prorated. Mr. Ferdman will also receive a
restricted stock award with respect to shares of the Company's common stock with
an aggregate grant date value of $4,000,000 (the "Extension Award"), generally
vesting one-third on each of the first three anniversaries of the Amendment
Effective Date. If Mr. Ferdman's employment is terminated as a result of the
expiration of the term, by the Company other than for cause or if Mr. Ferdman
resigns for good reason, the Extension Award will immediately vest and, if Mr.
Ferdman provides transition services through the Extended Term End Date, Mr.
Ferdman will receive the Bonus, prorated to the date of termination.



The foregoing description of the terms of the Amendment is qualified in its entirety by reference to the Amendment, a copy of which is filed as Exhibit 10.1 herewith and is incorporated by reference herein.




Item 8.01. Other Events



As a result of the entry into the Amendment, the Company has determined to
voluntarily supplement the Proxy Statement as described in this Current Report
on Form 8-K. These supplemental disclosures will not affect the merger
consideration to be paid to CyrusOne stockholders in connection with the Merger
or the timing of the special meeting of stockholders of the Company, which is
scheduled to be held on February 1, 2022 at 9:30 a.m., Central Time (10:30 a.m.,
Eastern Time), in a virtual-only meeting format, at
https://meetnow.global/MTUZUCT (the "Special Meeting"). The Board of Directors
of CyrusOne continues to recommend that you vote "FOR" the proposal to approve
the Merger in accordance with the terms of the Merger Agreement, the Merger
Agreement and the other transactions contemplated by the Merger Agreement and
"FOR" the other proposals being considered at the Special Meeting, including the
proposal to approve, by advisory (non-binding) vote, the compensation that may
be paid or become payable to the named executive officers of the Company in
connection with the consummation of the Merger.



Supplemental Disclosures to the Proxy Statement in Connection with the Amendment


The following disclosures in this Current Report on Form 8-K supplement the
disclosures contained in the Proxy Statement and should be read in conjunction
with the disclosures contained in the Proxy Statement, which in turn should be
read in its entirety. All page references are to the Proxy Statement and terms
used below, unless otherwise defined, shall have the meanings ascribed to such
terms in the Proxy Statement.

The disclosure in the section entitled "Treatment of Company Equity Awards" under the heading "The Merger", beginning on page 59 of the Proxy Statement, is hereby amended by:

Amending and restating the first full paragraph on page 60 as follows (with new text underlined):


The following table sets forth the value of the Company equity awards held by
each of the Company's directors, executive officers and Former Executive
Officers as of December 23, 2021, the latest practicable date to determine such
amounts before the filing of this proxy statement, and the cash amounts payable
(on a pre-tax basis) in respect thereof in connection with the merger. The
values in the table below have been determined assuming that (i) all Company
equity awards are valued based on the merger consideration of $90.50 per share,
(ii) all Company equity awards subject to performance criteria have such
criteria satisfied at the maximum levels, (iii) the merger closes on June 30,
2022, which is the assumed closing date only for purposes of this
compensation-related disclosure and (iv) the individuals included in the table
below do not receive any additional grants of Company equity awards or forfeit
any Company equity awards prior to June 30, 2022; however, such values do
reflect the expected grant of the Extension Award (as defined below) to Mr.
Ferdman and the expected vesting of Company equity awards prior to such date.
The values below also do not reflect any awards that were accelerated and vested
in accordance with the 280G mitigation actions described below. No director or
executive officer holds Company stock options or Company restricted shares.

Amending and restating the table on page 60 as follows:





                                            Company
                                          Restricted          Company        LTIP Units
Name (1)                                 Shares (2)($)      RSUs (2)($)        (2)($)         Total ($)
Executive Officers
David Ferdman                                 4,000,000                -               -       4,000,000
Katherine Motlagh                                     -                -       2,994,374       2,994,374
John Hatem                                            -                -       3,293,476       3,293,476
Robert Jackson                                        -        1,964,574       2,694,638       4,659,212
Former Executive Officers(3)                          -        7,056,014       2,555,901       9,611,915



Amending and restating footnote two to the table on page 60 as follows (with new text underlined):

(2) In the case of Company equity awards subject to performance criteria,

reflects achievement of such criteria at the maximum level. In the case of

Mr. Ferdman, includes the Extension Award, which is expected to be granted on


    or prior to February 8, 2022.



Amending and restating the two paragraphs beginning on page 60 under the sub-heading "-Employment Agreement with Mr. Ferdman", as follows (with new text underlined and deleted text marked with a strikethrough):

Mr. Ferdman is currently subject to an employment agreement, as amended, with a
term that ends on the earlier to occur of (a) the date that is 90 days following
the consummation of the merger and (b) January 29, 2023 January 29, 2022 (the
"Ferdman Term Date") and that provides that, if his employment terminates at the
Ferdman Term Date or is terminated without "Cause" or Mr. Ferdman resigns for
"Good Reason" (each, as defined in Mr. Ferdman's employment agreement) at any
time, he will be eligible to receive, subject to Mr. Ferdman's execution of a
release of claims in favor of the Company, (i) full vesting of the equity award
granted to him in connection with the extension of the term of his employment
agreement, which award will be granted on or prior to February 8, 2022 and have
a grant date value of $4,000,000 (the "Extension Award") his Company restricted
share award granted to him in his capacity as an employee and (ii) provided that
Mr. Ferdman provides transition services to the Company through the Ferdman Term
Date, an annual bonus, prorated to the date of termination the base salary and
annual bonus that Mr. Ferdman would have otherwise earned through the Ferdman
Term Date if his employment had not terminated. In addition, if Mr. Ferdman's
employment is terminated for any other reason, other than for Cause, he will be
entitled to a pro-rated portion of any annual bonus he would have otherwise
earned through the Ferdman Term Date January 29, 2023 if his employment had

not
terminated.









Mr. Ferdman's employment agreement does not provide for any enhanced payments or
benefits in connection with a change in control of the Company such as the
merger, but his previously granted Company restricted share award agreement
provides that, in the event that any payment or benefit payable to Mr. Ferdman
would constitute a parachute payment within the meaning of Section 280G of the
Internal Revenue Code of 1986, as amended (the "Code"), then Mr. Ferdman will
either receive all such payments and benefits in full or such payments and
benefits will be reduced to the greatest amount that does not trigger the excise
tax pursuant to Section 4999 of the Code, whichever results in the greater
after-tax amount for Mr. Ferdman (a "280G best-net cutback").



Amending and restating the second full paragraph on page 63 under the sub-heading "-Quantification of Payments and Benefits" as follows (with new text underlined):





The potential payments in the tables below are quantified in accordance with
Item 402(t) of Regulation S-K. The estimated values are based on (i) an
assumption that the merger is consummated on June 30, 2022, (ii) the per share
merger consideration of $90.50, (iii) the named executive officers' salary and
target bonus amounts as in effect as of the date of this proxy statement,
(iv) the number of unvested Company equity awards held by the named executive
officers as of December 23, 2021 (in particular, the amounts below exclude
awards that vested as a result of the 280G mitigation actions described above),
the latest practicable date to determine such amounts before the filing of this
proxy statement, less any awards expected to vest in the ordinary course prior
to June 30, 2022, and assuming no additional grants or forfeitures of Company
equity awards prior to June 30, 2022, other than the Extension Award, which will
be granted to Mr. Ferdman on or prior to February 8, 2022, and is included in
the estimated values below, and (v) an assumption that each named executive
officer experiences a termination of employment immediately following the
consummation of the merger under circumstances that entitle such named executive
officer to receive severance (i.e., a termination without "Cause" or resignation
for "Good Reason"). As such, the amounts indicated below are estimates based on
multiple assumptions that may or may not actually occur, including assumptions
described in this proxy statement, and do not reflect certain compensation
actions that may occur before consummation of the merger. As a result, the
actual amounts, if any, to be received by a named executive officer may
materially differ from the amounts set forth below.



Amending and restating the table on page 63 as follows:





                                                          Perquisites /
                                                            Benefits
Name(1)             Cash ($)(2)       Equity ($)(3)          ($)(4)           Total ($)
David Ferdman          4,838,356           4,000,000                   -       8,838,356
Katherine Motlagh      2,759,485           2,994,374              26,099       5,779,958
John Hatem             3,033,537           3,293,476              24,464       6,351,477
Robert Jackson         2,784,993           4,659,212              25,689       7,469,894



Deleting the second to last sentence in footnote two to the table on page 63.





Amending and restating the table in footnote two to the table on page 63 as
follows:



                                         Pro-Rata       Deal Retention
Name                 Severance ($)      Bonus ($)         Bonus ($)          Total ($)
David Ferdman                     -        838,356            4,000,000       4,838,356
Katherine Motlagh         2,011,540        247,945              500,000       2,759,485
John Hatem                1,810,386        223,151            1,000,000       3,033,537
Robert Jackson            1,589,117        195,877            1,000,000       2,784,993










Amending and restating footnote three (including the table thereto) to the table
on page 63 as follows (with new text underlined and deleted text marked with a
strikethrough):


(3) The amounts shown in this column represent the estimated aggregate value of

the named executive officers' unvested Company equity awards. As described in

the sections entitled "The Merger-Interests of the Company's Directors and

Executive Officers in the Merger-Treatment of Company Equity Awards" and "The

Merger-Treatment of Company Equity Awards," at the effective time, each

Company equity award will be canceled in exchange for the right to receive

the merger consideration with respect to each share of common stock subject

to the Company equity award, less the exercise price in the case of Company

stock options, and with the number of shares of common stock subject to any

awards subject to performance-criteria determined based on achievement of

such criteria at the maximum level, with such amounts in respect of Company

equity awards granted prior to the date of the merger agreement payable at

the effective time. Such amounts in respect of Company equity awards granted

after the date of the merger agreement will remain subject to any

time-vesting criteria that applied to the applicable Company equity award,

including with respect to any accelerated vesting terms upon a qualifying

termination of employment. As of the date of this proxy statement, all All

Company equity awards held by named executive officers other than Mr. Ferdman

were granted prior to the date of the merger agreement and no awards are

assumed to have been granted following the date of the merger agreement to

any such executive officer, and therefore the amounts shown in this column

for all executives other than Mr. Ferdman are "single-trigger" as such

payments will be payable on the effective time regardless of whether or not

the executive's employment is terminated. In the case of Mr. Ferdman, since

his Extension Award will be granted after the date of the merger agreement,

it will convert as of the effective time into a cash-based award subject to

the same vesting criteria, including accelerating upon a qualifying

termination of employment, and is therefore a "double-trigger" payment. No

values are shown for Mr. Ferdman because, based on the assumptions above, all

of his currently outstanding Company equity awards will vest in full prior to

the date on which the effective time is assumed to occur. A breakdown of the

amounts shown above by award type is provided in the sections entitled "The . . .

Item 9.01 Financial Statements and Exhibits.





(d) Exhibits



Exhibit No.   Description
  10.1          Amendment to Employment Agreement, dated as of January 25, 2022, by
              and between David H. Ferdman and CyrusOne Management Services LLC.
104           Cover Page Interactive Data File - the cover page XBRL tags are
              embedded within the Inline XBRL document.

© Edgar Online, source Glimpses